Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Henry Dumke"'
Autor:
Geoffrey Fell, Patrick Henrick, Efstathios Kastritis, Romanos Sklavenitis-Pistofidis, Steven P. Treon, David Liu, Robert J. Soiffer, Carl-Jannes Neuse, Kalvis Hornburg, Kimberly Noonan, Jorge J. Castillo, Meletios A. Dimopoulos, Mark Bustoros, Chia Jen Liu, Adriana Perilla-Glen, Irene M. Ghobrial, Henry Dumke, Jenny Soiffer, Catherine R. Marinac, Alexandra Savell, Bradley Rivotto, Cody J. Boehner, Amir Yosef, Kaitlen Reyes
Publikováno v:
Blood. 132:150-150
Background. Waldenström macroglobulinemia (WM) is a low-grade non-Hodgkin's lymphoplasmacytic lymphoma associated with overproduction of monoclonal IgM protein. It is preceded by an asymptomatic stage, called Smoldering Waldenström Macroglobulinemi
Autor:
Kenneth C. Anderson, Donna Neuberg, Romanos Sklavenitis-Pistofidis, Marzia Capelletti, Daniel Auclair, Kalvis Hornburg, Mark Bustoros, Tarek H. Mouhieddine, Irene M. Ghobrial, Brendan Reardon, Muhieddine M. Itani, Robert L. Schlossman, Jacob P. Laubach, Jerome Ritz, Jihye Park, Daisy Huynh, Salomon Manier, Chia Jen Liu, Paul G. Richardson, Nikhil C. Munshi, Christopher J. Gibson, Robert J. Soiffer, Eliezer M. Van Allen, Benjamin L. Ebert, Saud H. AlDubayan, Henry Dumke, Cody J. Boehner, Robert A. Redd, Amin Nassar, David P. Steensma
Publikováno v:
Blood. 132:749-749
Introduction: Multiple Myeloma (MM) is a clonal plasma cell malignancy, accounting for 10% of all hematological malignancies. Genetic analyses of large populations revealed that blood-specific somatic mutations in hematopoietic stem cells (HSCs) are
Autor:
Mark Bustoros, Chia-jen Liu, Kaitlen Reyes, Kalvis Hornburg, Kathleen Guimond, Rachel Styles, Alexandra Savell, Brianna Berrios, Diane Warren, Henry Dumke, Bradley Rivotto, Patrick Henrick, Emily Scranton, Houry Leblebjian, Kirsten Meid, Robert L. Schlossman, Nikhil Munshi, Jacob Laubach, Kenneth C. Anderson, Paul Richardson, Irene M. Ghobrial
Publikováno v:
Blood. 132:804-804
Background. This study aimed to determine the progression-free survival and response rate using early therapeutic intervention in patients with high-risk smoldering multiple myeloma (SMM) using the combination of ixazomib, lenalidomide, and dexametha